Humana (NYSE: HUM) reported Q3 EPS of $4.83, $0.17 better than the analyst estimate of $4.66. Revenue for the quarter came in at $20.7 billion versus the consensus estimate of $20.91 billion.

GUIDANCE:

Humana sees Q4 2021 EPS of $20.50, versus the consensus of $21.52.

• Humana is revising its GAAP EPS guidance range for the year ending December 31, 2021 (FY 2021) to approximately $23.67 from the previous range of $24.97 to $25.47. Humana is also revising its FY 2021 Adjusted EPS guidance to approximately $20.50 from the previous guidance range of $21.25 to $21.75. The current FY 2021 EPS guidance reflects the company’s updated view of utilization for the fourth quarter of 2021. Please see below for the company’s previous guidance commentary for reference, as well as detail of utilization assumptions included in the current FY 2021 guidance.

For earnings history and earnings-related data on Humana (HUM) click here.